Axenis' Acquisition

Axenis was acquired by Genoway on September 06, 2018.

Axenis designs and markets mouse models for preclinical studies, particularly in immunolo-oncology, immuno-inflammation, and infectiology.…

Articles about Axenis' Acquisition: